Sera Prognostics Net Income
| SERA Stock | USD 2.68 0.16 6.35% |
As of the 10th of February, Sera Prognostics has the Risk Adjusted Performance of 0.0016, coefficient of variation of (11,708), and Variance of 27.62. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sera Prognostics, as well as the relationship between them.
Sera Prognostics Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 593.6934 | Revenue | Earnings Share (0.76) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -29.6 M | -31.1 M | |
| Net Loss | -39.8 M | -41.8 M | |
| Net Loss | -29.6 M | -31.1 M | |
| Net Loss | (1.14) | (1.20) |
Sera | Net Income | Build AI portfolio with Sera Stock |
Analyzing Sera Prognostics's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Sera Prognostics's current valuation and future prospects.
Latest Sera Prognostics' Net Income Growth Pattern
Below is the plot of the Net Income of Sera Prognostics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Sera Prognostics financial statement analysis. It represents the amount of money remaining after all of Sera Prognostics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Sera Prognostics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sera Prognostics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (32.9 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Sera Net Income Regression Statistics
| Arithmetic Mean | (23,181,754) | |
| Coefficient Of Variation | (40.42) | |
| Mean Deviation | 8,228,387 | |
| Median | (16,521,000) | |
| Standard Deviation | 9,369,583 | |
| Sample Variance | 87.8T | |
| Range | 27.7M | |
| R-Value | (0.76) | |
| Mean Square Error | 39.1T | |
| R-Squared | 0.58 | |
| Significance | 0.0004 | |
| Slope | (1,416,167) | |
| Total Sum of Squares | 1404.6T |
Sera Net Income History
Other Fundumenentals of Sera Prognostics
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Sera Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Sera Prognostics is extremely important. It helps to project a fair market value of Sera Stock properly, considering its historical fundamentals such as Net Income. Since Sera Prognostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sera Prognostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sera Prognostics' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sera Prognostics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.76) | Revenue Per Share | Quarterly Revenue Growth (0.45) | Return On Assets | Return On Equity |
Understanding Sera Prognostics requires distinguishing between market price and book value, where the latter reflects Sera's accounting equity. The concept of intrinsic value - what Sera Prognostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Sera Prognostics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sera Prognostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Sera Prognostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sera Prognostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sera Prognostics.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Sera Prognostics on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Sera Prognostics or generate 0.0% return on investment in Sera Prognostics over 90 days. Sera Prognostics is related to or competes with Rapid Micro, Sharps Technology, Tevogen Bio, Cognition Therapeutics, Atossa Genetics, Lucid Diagnostics, and Apyx Medical. Sera Prognostics, Inc., a womens health diagnostic company, discovers, develops, and commercializes biomarker tests for ... More
Sera Prognostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sera Prognostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sera Prognostics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 27.77 | |||
| Value At Risk | (9.66) | |||
| Potential Upside | 8.62 |
Sera Prognostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sera Prognostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sera Prognostics' standard deviation. In reality, there are many statistical measures that can use Sera Prognostics historical prices to predict the future Sera Prognostics' volatility.| Risk Adjusted Performance | 0.0016 | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | (0.02) |
Sera Prognostics February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0016 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 3.86 | |||
| Coefficient Of Variation | (11,708) | |||
| Standard Deviation | 5.26 | |||
| Variance | 27.62 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 27.77 | |||
| Value At Risk | (9.66) | |||
| Potential Upside | 8.62 | |||
| Skewness | 0.1616 | |||
| Kurtosis | 1.1 |
Sera Prognostics Backtested Returns
Sera Prognostics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0308, which indicates the firm had a -0.0308 % return per unit of risk over the last 3 months. Sera Prognostics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sera Prognostics' Variance of 27.62, coefficient of variation of (11,708), and Risk Adjusted Performance of 0.0016 to confirm the risk estimate we provide. The entity has a beta of 2.29, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sera Prognostics will likely underperform. At this point, Sera Prognostics has a negative expected return of -0.14%. Please make sure to validate Sera Prognostics' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day median price , to decide if Sera Prognostics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.53 |
Good reverse predictability
Sera Prognostics has good reverse predictability. Overlapping area represents the amount of predictability between Sera Prognostics time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sera Prognostics price movement. The serial correlation of -0.53 indicates that about 53.0% of current Sera Prognostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.53 | |
| Spearman Rank Test | -0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.14 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Sera Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Sera Prognostics reported net income of (32.9 Million). This is 109.64% lower than that of the Biotechnology sector and 119.0% lower than that of the Health Care industry. The net income for all United States stocks is 105.76% higher than that of the company.
Sera Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sera Prognostics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sera Prognostics could also be used in its relative valuation, which is a method of valuing Sera Prognostics by comparing valuation metrics of similar companies.Sera Prognostics is currently under evaluation in net income category among its peers.
Sera Prognostics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Sera Prognostics from analyzing Sera Prognostics' financial statements. These drivers represent accounts that assess Sera Prognostics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Sera Prognostics' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 211.4M | 39.0M | 186.6M | 269.9M | 242.9M | 151.7M | |
| Enterprise Value | 152.6M | 11.9M | 184.6M | 266.7M | 240.0M | 137.3M |
Sera Prognostics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sera Prognostics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sera Prognostics' managers, analysts, and investors.Environmental | Governance | Social |
Sera Prognostics Institutional Holders
Institutional Holdings refers to the ownership stake in Sera Prognostics that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Sera Prognostics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sera Prognostics' value.| Shares | Blackrock Inc | 2025-06-30 | 145.3 K | Perkins Capital Management Inc | 2025-06-30 | 131 K | State Street Corp | 2025-06-30 | 121.6 K | Ci Private Wealth Llc | 2025-06-30 | 100 K | Wealth Enhancement Advisory Services, Llc | 2025-06-30 | 99.2 K | Northern Trust Corp | 2025-06-30 | 91.6 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 91.4 K | Squarepoint Ops Llc | 2025-06-30 | 85.4 K | Cliftonlarsonallen Wealth Advisors, Llc | 2025-06-30 | 78.9 K | Baker Bros Advisors Lp | 2025-06-30 | 5.5 M | Whetstone Capital Advisors, Llc | 2025-06-30 | 3.6 M |
Sera Fundamentals
| Return On Equity | -0.48 | ||||
| Return On Asset | -0.25 | ||||
| Operating Margin | (561.25) % | ||||
| Current Valuation | 56.4 M | ||||
| Shares Outstanding | 37.63 M | ||||
| Shares Owned By Insiders | 10.63 % | ||||
| Shares Owned By Institutions | 57.74 % | ||||
| Number Of Shares Shorted | 337.66 K | ||||
| Price To Book | 1.18 X | ||||
| Price To Sales | 1,024 X | ||||
| Revenue | 77 K | ||||
| Gross Profit | (59 K) | ||||
| EBITDA | (32.04 M) | ||||
| Net Income | (32.9 M) | ||||
| Cash And Equivalents | 106.91 M | ||||
| Cash Per Share | 3.45 X | ||||
| Total Debt | 840 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.80 X | ||||
| Book Value Per Share | 2.13 X | ||||
| Cash Flow From Operations | (14.19 M) | ||||
| Short Ratio | 5.25 X | ||||
| Earnings Per Share | (0.76) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 63 | ||||
| Beta | 0.99 | ||||
| Market Capitalization | 97.26 M | ||||
| Total Asset | 72.58 M | ||||
| Retained Earnings | (279.79 M) | ||||
| Working Capital | 22.83 M | ||||
| Net Asset | 72.58 M |
About Sera Prognostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sera Prognostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sera Prognostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sera Prognostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sera Prognostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sera Prognostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sera Prognostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sera Prognostics Stock:Check out For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sera Prognostics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.76) | Revenue Per Share | Quarterly Revenue Growth (0.45) | Return On Assets | Return On Equity |
Understanding Sera Prognostics requires distinguishing between market price and book value, where the latter reflects Sera's accounting equity. The concept of intrinsic value - what Sera Prognostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Sera Prognostics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sera Prognostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.